SHILPA MEDICARE LIMITED Share Price & Technical Analysis
SHILPAMED · ₹1,047 (-0.81%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹1,047
-0.81%
Shilpa Medicare Limited offers pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation (CDMO) services in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, axitinib, azacitidine, abiraterone acetat…
Price chart
Seasonality
Oct has 1 positive and 3 negative years (last 5 years shown)
140% return in 2026, 32% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -10% | 17% | 10% | 13% | 23% | 19% | 4% | 54% | 10% | – | – | – | 140% |
| 25 | -13% | -12% | 7% | -2% | 40% | -1% | -1% | -4% | -11% | -7% | -4% | -6% | -16% |
| 24 | 12% | 14% | 10% | 19% | -12% | 14% | 20% | 12% | 6% | 4% | 6% | -11% | 93% |
| 23 | -12% | 4% | -11% | 11% | -7% | 19% | 24% | 3% | -3% | -2% | 3% | -10% | 19% |
| 22 | -6% | -20% | -2% | 15% | -5% | -9% | 6% | -6% | -1% | -18% | -11% | -8% | -65% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Strong
Shilpa Medicare Limited offers pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation (CDMO) services in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, axitinib, azacitidine, abiraterone acetate, bendamustine HCL monohydrate, bicalutamide, bortezomib, busulphan, cabazitaxel amorphous, capecitabine, clofarabine, cyclophosphamide, dasatinib, decitabine, dimethyl fumarate, erlotinib HCL, enzalutamide, fingolimod hydrochloride, gemcitabine HCl, ibrutinib, imatinib mesylate, irinotecan HCl trihydrate, lenalidomide, lenvatinib mesylate, letrozole, and melphalan HCL. It also provides nifedipine, oxaliplatin, pazopanib, pemetrexed disodium hemipentahydrate, pemetrexed dipotassium nonahydrate, pirfenidone, pomalidomide, sodium cholesteryl sulfate, sorafenib tosylate, sunitinib malate, temozolomide, teriflunomide, thalidomide, tranexamic and zoledronic acid, phenylephrine, citicholine, palbocicilib, nilotinib, nintedanib, praziquintol, carmustine, elthrombopag olamine, abacavir sulphate, tenofovir disproxyl fumarate API, tenofovir alfanamide, prucalopride succinate, and varenicline tartrate. In addition, the company offers GLP-1; HpAPI; intermediates; peptides; payloads and linkers; biopolymers; microbial and mammalian products; fermentation; small molecules; monoclonal antibodies and recombinant technology; and tablets, capsules, injectables, oral dissolving films, and transdermal patches. Further, it engages in wind power generation activities. The company serves wholesalers, distributors, doctors, pharmacy chain NGOs, hospitals, government institutions, and companies. The company was formerly known as Shilpa Antibiotics Ltd and changed its name to Shilpa Medicare Limited in February 2003. Shilpa Medicare Limited was incorporated in 1987 and is based in Raichur, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹202.07B
P/E ratio
67.93
52W high
₹1,075
52W low
₹259.5
Volume
4,91,714
Beta
0.37
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,731
Frequently asked questions
- What is SHILPA MEDICARE LIMITED share price today?
- SHILPA MEDICARE LIMITED (SHILPAMED) last traded around ₹1,047 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SHILPAMED have?
- StockPro currently tracks 1 active signal(s) for SHILPAMED, including breakouts, momentum, and volume patterns. See the signals panel on this page.
- How can I analyze SHILPA MEDICARE LIMITED stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.